Wall Street Zen downgraded shares of Afya (NASDAQ:AFYA – Free Report) from a buy rating to a hold rating in a research note published on Monday,Wall Street Zen reports.
AFYA has been the subject of several other reports. Bradesco Corretora upgraded Afya to an “outperform” rating and set a $17.00 price objective for the company in a report on Thursday, September 24th. Weiss Ratings lowered shares of Afya from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, October 29th. JPMorgan Chase & Co. dropped their target price on shares of Afya from $19.00 to $17.50 and set an “overweight” rating on the stock in a report on Tuesday, November 3rd. Zacks Research cut shares of Afya from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 3rd. Finally, Bank of America raised shares of Afya from a “neutral” rating to a “buy” rating and set a $16.00 target price on the stock in a research report on Thursday, October 29th. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $15.18.
View Our Latest Stock Report on Afya
Afya Trading Down 2.8%
AFYA opened at $10.04 on Monday. The stock’s fifty day moving average is $12.73 and its two-hundred day moving average is $13.98. The company has a market capitalization of $940.57 million, a P/E ratio of 5.80, a PEG ratio of 1.66 and a beta of 0.43. Afya has a 52 week low of $9.66 and a 52 week high of $16.16. The company has a quick ratio of 2.20, a current ratio of 2.20 and a debt-to-equity ratio of 0.39.
Insider Transactions at Afya
In other Afya news, insider Santos Welder Ferreira sold 4,161 shares of the business’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the transaction, the insider directly owned 35,000 shares in the company, valued at approximately $465,500. The trade was a 10.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Institutional Trading of Afya
Institutional investors have recently modified their holdings of the company. Public Employees Retirement System of Ohio acquired a new stake in Afya in the second quarter valued at approximately $67,000. R Squared Ltd increased its position in shares of Afya by 37.0% during the third quarter. R Squared Ltd now owns 60,114 shares of the company’s stock worth $724,000 after purchasing an additional 16,250 shares in the last quarter. Dodge & Cox increased its position in shares of Afya by 33.5% during the third quarter. Dodge & Cox now owns 68,487 shares of the company’s stock worth $825,000 after purchasing an additional 17,200 shares in the last quarter. Entropy Technologies LP purchased a new stake in shares of Afya during the 3rd quarter valued at $246,000. Finally, Engineers Gate Manager LP purchased a new stake in shares of Afya during the 2nd quarter valued at $325,000. 88.02% of the stock is currently owned by institutional investors.
Afya Company Profile
Afya Limited is a Brazilian medical education and digital health company. Its education business offers undergraduate medical degree programs, medical residency preparation, postgraduate courses and continuing education for health professionals. The company also provides digital tools and services for medical students and practicing physicians, including clinical reference, practice-management and learning resources. These offerings support professionals at different stages of their medical careers.
See Also
- Five stocks we like better than Afya
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
